LD-2 disclosure · 3rd Quarter - Report
VIR BIOTECHNOLOGY, INC.
via VIR BIOTECHNOLOGY, INC.
Client
- Name
- VIR BIOTECHNOLOGY, INC.
- Location
- California · United States of America
Registrant
- Firm
- VIR BIOTECHNOLOGY, INC.
- Description
- Commercial-stage immunology company
- Location
- San Francisco, California, United States of America
Lobbying activities
5 issuesTaxation/Internal Revenue Code
S. 866, American Innovation and Jobs Act; H.R. 2673, American Innovation and R&D Competitiveness Act; H.R. 3938, Build It In America Act
LobbyistsDOUGLAS STOSS
TargetedSENATE · HOUSE OF REPRESENTATIVES
Trade (domestic/foreign)
COVID-19 Trade Related Aspects of Intellectual Property Rights Waiver
LobbyistsDOUGLAS STOSS
TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office · Natl Security Council (NSC) · U.S. International Trade Commission (ITC)
Health Issues
Pandemic Preparedness Funding, Influenza Preparedness; COVID-19 Response and Therapeutics Procurement and Distribution; FY 2024 Labor-HHS Appropriations; Pandemic and All-Hazards Preparedness Act Reauthorization
LobbyistsDOUGLAS STOSS
TargetedSENATE · HOUSE OF REPRESENTATIVES · Office of Science & Technology Policy (OSTP) · Health & Human Services, Dept of (HHS) · Centers For Disease Control & Prevention (CDC)